Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Sep;151(3):647–649.

Role of interleukin-6 in the pathogenesis of murine plasmacytoma and human multiple myeloma.

P K Pattengale 1
PMCID: PMC1857849  PMID: 9284811

Full text

PDF
647

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bataille R., Chappard D., Klein B. Mechanisms of bone lesions in multiple myeloma. Hematol Oncol Clin North Am. 1992 Apr;6(2):285–295. [PubMed] [Google Scholar]
  2. Bataille R., Harousseau J. L. Multiple myeloma. N Engl J Med. 1997 Jun 5;336(23):1657–1664. doi: 10.1056/NEJM199706053362307. [DOI] [PubMed] [Google Scholar]
  3. Byrd L. G., McDonald A. H., Gold L. G., Potter M. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane. J Immunol. 1991 Nov 15;147(10):3632–3637. [PubMed] [Google Scholar]
  4. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994 Dec 16;266(5192):1865–1869. doi: 10.1126/science.7997879. [DOI] [PubMed] [Google Scholar]
  5. Fearon D. T., Locksley R. M. The instructive role of innate immunity in the acquired immune response. Science. 1996 Apr 5;272(5258):50–53. doi: 10.1126/science.272.5258.50. [DOI] [PubMed] [Google Scholar]
  6. Felix K., Potter M., Bornkamm G. W., Janz S. In vitro mutagenicity of the plasmacytomagenic agent pristane (2,6,10,14-tetramethylpentadecane). Cancer Lett. 1997 Feb 26;113(1-2):71–76. doi: 10.1016/s0304-3835(97)04597-7. [DOI] [PubMed] [Google Scholar]
  7. Hardin J., MacLeod S., Grigorieva I., Chang R., Barlogie B., Xiao H., Epstein J. Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood. 1994 Nov 1;84(9):3063–3070. [PubMed] [Google Scholar]
  8. Hilbert D. M., Kopf M., Mock B. A., Köhler G., Rudikoff S. Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med. 1995 Jul 1;182(1):243–248. doi: 10.1084/jem.182.1.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hilbert D. M., Shen M. Y., Rapp U. R., Rudikoff S. T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):649–653. doi: 10.1073/pnas.92.3.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hirano T., Suematsu S., Matsusaka T., Matsuda T., Kishimoto T. The role of interleukin 6 in plasmacytomagenesis. Ciba Found Symp. 1992;167:188–200. doi: 10.1002/9780470514269.ch12. [DOI] [PubMed] [Google Scholar]
  11. Janz S., Jones G. M., Müller J. R., Potter M. Genomic instability in B-cells and diversity of recombinations that activate c-myc. Curr Top Microbiol Immunol. 1995;194:373–380. doi: 10.1007/978-3-642-79275-5_43. [DOI] [PubMed] [Google Scholar]
  12. Lattanzio G., Libert C., Aquilina M., Cappelletti M., Ciliberto G., Musiani P., Poli V. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. Am J Pathol. 1997 Sep;151(3):689–696. [PMC free article] [PubMed] [Google Scholar]
  13. McDonald A. H., Byrd L. G., Mainhart C. R., Sopher J., Smith-Gill S. J. Plasmacytoma-refractory BALB/cAnPt mice have naive T cell and highly specific B cell responses to antigen. Mol Immunol. 1996 Oct;33(15):1183–1196. doi: 10.1016/s0161-5890(96)00103-4. [DOI] [PubMed] [Google Scholar]
  14. Mock B. A., Krall M. M., Dosik J. K. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9499–9503. doi: 10.1073/pnas.90.20.9499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Moore P. S., Boshoff C., Weiss R. A., Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 1996 Dec 6;274(5293):1739–1744. doi: 10.1126/science.274.5293.1739. [DOI] [PubMed] [Google Scholar]
  16. Müller J. R., Jones G. M., Janz S., Potter M. Migration of cells with immunoglobulin/c-myc recombinations in lymphoid tissues of mice. Blood. 1997 Jan 1;89(1):291–296. [PubMed] [Google Scholar]
  17. Nishimoto N., Shima Y., Yoshizaki K., Kishimoto T. Myeloma biology and therapy. Present status and future developments. Hematol Oncol Clin North Am. 1997 Feb;11(1):159–172. doi: 10.1016/s0889-8588(05)70421-4. [DOI] [PubMed] [Google Scholar]
  18. Potter M., Wiener F. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis. 1992 Oct;13(10):1681–1697. doi: 10.1093/carcin/13.10.1681. [DOI] [PubMed] [Google Scholar]
  19. Rettig M. B., Ma H. J., Vescio R. A., Põld M., Schiller G., Belson D., Savage A., Nishikubo C., Wu C., Fraser J. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science. 1997 Jun 20;276(5320):1851–1854. doi: 10.1126/science.276.5320.1851. [DOI] [PubMed] [Google Scholar]
  20. Silva S., Babonits M., Klein G. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15. Genes Chromosomes Cancer. 1996 Nov;17(3):179–184. doi: 10.1002/(SICI)1098-2264(199611)17:3<179::AID-GCC6>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  21. Suematsu S., Matsusaka T., Matsuda T., Ohno S., Miyazaki J., Yamamura K., Hirano T., Kishimoto T. Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):232–235. doi: 10.1073/pnas.89.1.232. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES